Scientometrics
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 6, 2024; 12(19): 3908-3917
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3908
Global current research status and future hotspots in osteoporotic fracture based on bibliometric assessment and visualization techniques
Yu-Ming Wang, Ping Yi
Yu-Ming Wang, Ping Yi, Department of Spine Surgery, China-Japan Friendship Hospital, Beijing 100029, China
Author contributions: Wang YM and Yi P have participated sufficiently in the work to take public responsibility for appropriate portions of the content and agreed to be accountable for all aspects of the work in ensuring that questions related to its accuracy or integrity.
Conflict-of-interest statement: The authors declare that there is no competing interest associated with the manuscript.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ping Yi, MD, Professor, China-Japan Friendship Hospital, Department of Spine Surgery, No. 2 East Yinghua Street, Chaoyang District, Beijing 100029, China. cjfh_ypspine@163.com
Received: March 10, 2024
Revised: April 26, 2024
Accepted: May 22, 2024
Published online: July 6, 2024
Processing time: 110 Days and 21.7 Hours
Abstract
BACKGROUND

In the past decade, the evolution of themes in the field of osteoporotic fractures has changed from epidemiology and prediction of long-term morbidity, risk assessment of osteoporotic fractures, and zoledronic acid and denosumab in the treatment of osteoporosis to treatment guidelines for osteoporosis and the side effects caused by anti-osteoporotic drugs.

AIM

To understand the trends and hotspots in osteoporotic fracture research.

METHODS

Original articles were retrieved between January 1, 2010, and December 31, 2019, from the Web of Science Core Collection database. CiteSpace software facilitated the analysis and visualization of scientific productivity and emerging trends.

RESULTS

Nine studies were identified using bibliometric indices, including citation, centrality, and sigma value, which might indicate a growing trend. Through clustering, we identified six major hot subtopics. Using burst analysis, top-5 references with the strongest bursting strength after 2017 were identified, indicating a future hotspot in this field.

CONCLUSION

Current hot subtopics in osteoporotic fracture research include atypical femoral fractures, androgen deprivation therapy, denosumab discontinuation, hip fractures, trabecular bone score (TBS), and bone phenotype. Management and prevention of secondary fractures in patients with osteoporotic fractures, TBSs, and long-term administration strategy for zoledronic acid are expected to become research hotspots.

Keywords: Osteoporotic fracture; Bibliometrics; Trabecular bone score; Co-occurrence analysis; Co-citation analysis; Clustering

Core Tip: The evolution process of the research focus in the field of osteoporosis fractures in the past decade has changed from epidemiological statistics and long-term incidence prediction to osteoporosis fracture risk assessment and significant effects of zoledronic acid and denosumab on reducing fracture risk in osteoporosis treatment to the proposal of osteoporosis treatment guidelines and the adverse reactions caused by anti-osteoporosis drugs such as zoledronic acid. Current hot topics in the treatment of osteoporosis fractures include atypical femoral fractures, osteoporosis fractures caused by androgen deprivation, increased fracture risk due to denosumab discontinuation, hip fractures, trabecular bone scores, and genes related to bone density or osteoporosis fracture phenotypes.